Haemochromatosis
11 Sept 2026 · 18 min read

On this page45 sections
Haemochromatosis is a hereditary genetic disorder characterized by iron overload—a systemic accumulation of iron in the body over many years. Because the human body lacks a natural mechanism to excrete excess iron, the surplus is progressively deposited into vital organs. Without early diagnosis and treatment, this toxic buildup can cause severe, irreversible structural damage to the liver, pancreas, heart, and joints.
Clinical Symptoms
Symptoms of hereditary haemochromatosis typically manifest in midlife, usually emerging between the ages of 30 and 60. The clinical presentation is highly variable and can initially resemble other common health issues:
Systemic: Chronic, unremitting fatigue, unexplained weight loss, and generalized physical weakness.
Musculoskeletal: Persistent, debilitating joint pain (arthropathy), frequently affecting the knuckles and wrists first.
Endocrine & Reproductive: Inability to achieve or sustain an erection (erectile dysfunction) in men, or irregular, missing periods (amenorrhea) in women, driven by iron deposition in the pituitary gland.
Diagnosis and Testing Protocols
Confirming a diagnosis early is crucial to prevent long-term organ damage.
Initial Blood Panels: Diagnosed using specific iron-monitoring blood tests, primarily measuring transferrin saturation and serum ferritin levels.
Specialist Referrals: If these panels indicate iron overload, your GP will refer you to a hospital-based specialist, such as a hematologist or gastroenterologist.
Advanced Staging Scans: Additional diagnostic tools, including genetic blood testing, liver ultrasounds, or specialized liver MRI scans, may be performed to assess whether the condition has caused structural tissue damage.
Genetic Causes and Inheritance Patterns
Haemochromatosis is an autosomal recessive condition caused by a mutation or fault in the HFE gene, which controls how the digestive system absorbs iron from food.
Understanding Inheritance:
Two Mutated Genes Required: A child must inherit one copy of the faulty gene from their mother and one from their father to be at risk for the condition.
The Carrier State: If you only inherit the mutated gene from one parent, you will not develop haemochromatosis, but you will be a genetic carrier and can pass the mutation to your offspring.
Variable Penetrance: Inheriting two copies of the mutated gene does not guarantee you will develop iron overload. Only a portion of individuals with two copies ever manifest clinical symptoms, a phenomenon known as incomplete penetrance, the exact triggers of which are still being researched.
Treatment and Clinical Management
While there is no permanent cure to reverse the genetic mutation, haemochromatosis is highly manageable. Treatments focus entirely on reducing your body's circulating iron levels to safeguard your organs.
1. Venesection (Therapeutic Phlebotomy)
Venesection is the gold standard and most effective treatment. The procedure removes a specific volume of blood from a vein, mirroring a standard blood donation.
The Mechanism: Removing blood forces the body to deplete its tissue iron stores to manufacture new red blood cells.
Frequency: In the initial "induction" phase, venesections may be required weekly to aggressively lower iron levels. Once target ferritin levels are achieved, you will transition into a lifelong maintenance phase, requiring treatments only a few times a year.
2. Dietary Adjustments
If you are undergoing regular therapeutic venesection, drastic dietary restrictions are generally unnecessary. However, clinicians often advise avoiding iron supplements, limiting highly fortified cereals, and avoiding raw shellfish due to an increased susceptibility to specific bacterial infections in high-iron environments.
Potential Complications of Delayed Treatment
If iron overload is left undetected or untreated, the chronic cellular toxicity leads to severe, life-threatening complications:
Hepatotoxicity: Advanced scarring of the liver tissue (cirrhosis), which drastically increases the risk of developing hepatocellular carcinoma (liver cancer).
Secondary Diabetes: Direct iron damage to the islet cells of the pancreas, impairing insulin production (historically called "bronze diabetes").
Severe Arthropathy: Destructive, chronic arthritis and permanent joint deformities.
Cardiomyopathy: Iron infiltration into the heart muscle, leading to arrhythmias and progressive congestive heart failure.
When to Seek Medical Attention
Non-Urgent Care
Schedule a consultation with your GP if you develop chronic fatigue, persistent joint pain, or other worrying symptoms. Furthermore, if you have a first-degree biological relative (a parent, brother, or sister) diagnosed with haemochromatosis, you should ask your GP for preventative iron screening, even if you currently feel entirely healthy.
Timeline and Onset of Symptoms
Clinical manifestations of hereditary haemochromatosis typically emerge in midlife, usually between the ages of 30 and 60, though onset can occur earlier or later in life.
Gender Differences: Symptoms generally develop earlier in men than in women. Biological women are naturally protected against early iron accumulation due to regular blood loss through menstruation and pregnancy. Consequently, symptoms in women frequently do not manifest until after menopause.
Asymptomatic Presentation: In many cases, individuals exhibit no outward physical symptoms at all. The condition is often discovered incidentally via elevated iron markers on a routine baseline blood panel.
Early Symptoms of Haemochromatosis
During the initial stages of iron accumulation, symptoms can be subtle and easily mistaken for other common health issues. Early indicators include:
Systemic: Chronic, profound fatigue that does not improve with rest, unexplained weight loss, and generalised physical weakness.
Musculoskeletal: Persistent joint pain (arthropathy), which frequently targets the knuckles and wrists first.
Cognitive & Mood Changes: Pronounced brain fog (difficulty concentrating), uncharacteristic mood swings, heightened anxiety, and depression.
Endocrine & Reproductive: Infertility or reproductive changes driven by iron accumulation in the pituitary gland. This includes erectile dysfunction (difficulty achieving or sustaining an erection) in men, and irregular or completely absent periods (amenorrhea) in women.
Advanced Symptoms and Complications
If iron overload is left undetected and untreated over many years, the chronic toxicity leads to cellular damage within vital organs, resulting in more severe symptoms:
Hormonal & Sexual Decline: A significant, permanent loss of sex drive (libido) in all genders, and testicular atrophy (shrinkage of the testicles) in men.
Dermatological (Hyperpigmentation): A distinct darkening or bronzing of the skin. In light-skinned individuals, this can present as a permanent, deep tan despite minimal sun exposure.
Hepatic (Liver Distress): Chronic abdominal pain, abdominal distension or swelling (ascites), and jaundice (yellowing of the skin and the whites of the eyes, which can be subtler or harder to visually evaluate on black or brown skin).
Pancreatic (Secondary Diabetes): Extreme, unremitting thirst (polydipsia) and frequent urination (polyuria), which indicate the onset of secondary diabetes caused by pancreatic tissue damage.
Progressive Arthropathy: Severe, chronic joint pain accompanied by permanent stiffness, particularly localized in the finger and hand joints.
Cardiovascular Failure: Chronic chest pain, shortness of breath (dyspnea), peripheral oedema (swollen hands, ankles, and feet), and cardiac arrhythmias (an irregular or skipping heartbeat).
When to Seek Medical Attention
Non-Urgent Care
Schedule a consultation with your General Practitioner (GP) if you develop long-lasting, unexplained fatigue, persistent joint pain, or any other worrying symptoms listed above.
Furthermore, because haemochromatosis is a hereditary genetic condition, you should ask your GP for preventative iron screening if you have a first-degree biological relative (a parent, brother, or sister) diagnosed with the disorder, even if you currently feel entirely healthy.
Pathophysiology and the HFE Gene
Hereditary haemochromatosis is caused by a mutation or fault in the HFE gene. Under normal physiological conditions, the HFE gene regulates how much iron the digestive tract absorbs from food.
When this gene is mutated, the body loses its natural ability to control iron regulation. Instead of absorbing only what it requires, the gastrointestinal tract continuously absorbs an excess of dietary iron. Because the body has no natural path to excrete surplus iron, the circulating iron levels steadily escalate over decades. This surplus is progressively deposited into vital organs and joint capsules, eventually leading to cellular toxicity and structural damage.
Genetic Inheritance: Autosomal Recessive Pattern
Haemochromatosis is inherited in an autosomal recessive pattern. This means a child must receive two copies of the mutated HFE gene—one from each biological parent—to be at risk of developing the disorder.
1. The Carrier State
If an individual inherits the mutated gene from only one parent, they will not develop iron overload or experience symptoms of haemochromatosis. However, they are clinically classified as a genetic carrier. Carriers have a 1 in 2 (50%) statistical chance of passing the faulty gene on to their future biological children.
Prevalence Note: Being a carrier of the mutated HFE gene is highly prevalent in certain ethnic groups. It is particularly common in individuals of Celtic or Northern European descent, making haemochromatosis one of the most common genetic disorders in Ireland.
2. Statistical Chances for Carrier Parents
When both biological parents are asymptomatic carriers of the mutated HFE gene, each individual pregnancy carries the following statistical probabilities:
1 in 4 (25%) chance: The child will inherit two completely normal genes. They will not have haemochromatosis and will not be a carrier.
1 in 2 (50%) chance: The child will inherit one normal gene and one mutated gene. They will not develop the condition but will be an asymptomatic carrier.
1 in 4 (25%) chance: The child will inherit two copies of the mutated gene, putting them at risk for developing haemochromatosis.
Understanding Genetic Penetrance
It is important to note that inheriting two copies of the mutated HFE gene does not guarantee that you will develop clinical iron overload.
The condition exhibits what geneticists call low penetrance, meaning only a small percentage of individuals who possess the double mutation go on to accumulate harmful levels of iron and manifest symptoms. The precise environmental, dietary, or secondary genetic factors that trigger the active progression of the disease in some individuals while leaving others unaffected remain an active area of medical research.
Clinical Assessment
Because the early symptoms of hereditary haemochromatosis mirror many other common medical conditions, a definitive diagnosis relies heavily on objective laboratory testing and imaging.
When to Seek Testing:
Symptomatic Patients: Schedule a consultation with your General Practitioner (GP) if you experience unexplained, long-lasting fatigue, chronic joint pain, or other symptoms of iron overload.
Family History: If you have a first-degree biological relative (a parent, brother, or sister) diagnosed with haemochromatosis, you should request a preventative evaluation, even if you currently feel entirely healthy.
Phase 1: Iron Biomarker Blood Tests
Your GP will initially order a targeted iron panel to measure specific biochemical markers in your blood. These tests are frequently performed in stages:
Transferrin Saturation Level: Measures the percentage of transferrin (a blood protein) that is actively bound to iron, reflecting the immediate amount of circulating iron in your blood. A value higher than 45% suggests potential iron overload.
Serum Ferritin Level: Evaluates the total amount of iron currently stored within your body's tissues. Clinical concern for haemochromatosis is triggered if ferritin levels exceed 300 ng/mL in men or 200 ng/mL in women.
Phase 2: Confirming with Genetic Testing
If your iron biomarker blood tests reveal hyperferritinemia or elevated transferrin saturation, your GP will arrange a targeted genetic blood test. This analysis maps your DNA to check for specific mutations in the HFE gene.
The genetic results will definitively categorize your status:
Confirmed Haemochromatosis: You have inherited two copies of the mutated HFE gene (homozygous), putting you at risk for active iron overload.
Genetic Carrier: You have inherited only one copy of the mutated gene (heterozygous). You will not develop the condition but can pass the mutation to your biological children.
Negative: You do not harbor the specific HFE gene mutations.
Phase 3: Differential Diagnosis and Ruling Out Secondary Iron Overload
An elevated iron panel does not automatically mean you have genetic haemochromatosis. Your GP must rule out other underlying factors that cause secondary iron overload, which include:
Chronic, long-term liver diseases (such as fatty liver disease or hepatitis).
Conditions requiring recurrent blood transfusions (e.g., sickle cell disease or thalassaemia).
Chronic alcohol misuse.
Long-term renal dialysis therapies.
Unsupervised or excessive intake of iron supplements or therapeutic iron injections.
Rare, alternative inherited disorders that affect red blood cell production.
Phase 4: Specialist Referral and Organ Damage Staging
If your genetic and iron tests confirm haemochromatosis, your GP will refer you to a hospital-based specialist (such as a haematologist or gastroenterologist). The specialist will order advanced staging tests to evaluate whether the chronic iron buildup has caused structural tissue or organ damage:
1. Hepatic (Liver) Evaluation
MRI Scan: A non-invasive imaging tool utilized to quantify the exact concentration of iron deposited within the liver tissue and to screen for scarring.
Liver Biopsy: In specific complex cases, a clinician uses a fine needle to extract a microscopic tissue sample from the liver to directly evaluate for advanced scarring (cirrhosis) or cellular changes.
2. Systemic and Endocrine Staging
Cardiovascular Checks: An electrocardiogram (ECG) or an echocardiogram (ultrasound of the heart) to evaluate cardiac rhythm, chamber size, and heart muscle function.
Metabolic & Endocrine Screening: Targeted blood panels to check for secondary diabetes (pancreatic damage) or signs of Addison’s disease (adrenal gland insufficiency).
Musculoskeletal Assessments: Specific blood or physical tests to evaluate for iron-induced arthritis.
DEXA Scan: A specialized, low-dose X-ray utilized to measure bone mineral density and evaluate for osteoporosis, which can be accelerated by chronic iron overload.
Treatment Goals
While there is no permanent cure to reverse the underlying genetic mutation of hereditary haemochromatosis, the condition is highly manageable. Clinical treatment focuses on aggressively reducing systemic iron levels. Lowering your body's iron burden helps alleviate early symptoms—such as chronic fatigue and joint pain—and drastically reduces the long-term risk of severe structural damage to the heart, liver, and pancreas.
Therapeutic Venesection (Phlebotomy)
The primary treatment and gold standard for managing iron overload is therapeutic venesection (also known as a phlebotomy). The procedure is clinically identical to a standard blood donation.
How It Works:
Targeted Removal: The procedure removes a specific volume of blood, which contains millions of iron-rich red blood cells.
Tissue Depletion: To replace these lost red blood cells, your bone marrow is forced to draw excess iron out of your organs and tissues, safely lowering your overall bodily iron stores.
The Two Clinical Phases of Treatment:
Induction Phase: In the initial stage of treatment, blood is typically removed on a weekly basis. This intensive schedule is maintained until your serum ferritin and transferrin saturation levels return to a safe, normal baseline. Most patients begin to notice a significant improvement in their energy levels within a few months of starting induction.
Maintenance Phase: Once your iron markers are stabilized, you will transition into a lifelong maintenance phase. During this stage, venesections are only required 2 to 4 times a year to prevent iron from re-accumulating.
Side Effect Note: It is normal to feel briefly dizzy, lightheaded, or faint immediately following a venesection, but these symptoms typically resolve quickly with rest and hydration.
Accessing Treatment
Your General Practitioner (GP) may perform the venesection directly at their clinic, or they may refer you to a specialized day-ward at a local hospital.
Additionally, many individuals living with well-managed haemochromatosis are eligible to donate their blood. If you meet the standard donor criteria, your maintenance phlebotomies can be performed at a public blood bank, allowing your therapeutic blood removal to help save the lives of others. For localized criteria and donor clinics in Ireland, you can consult resources like the Irish Blood Transfusion Service at giveblood.ie.
Dietary and Lifestyle Modifications
If you are undergoing regular therapeutic venesection, major or highly restrictive dietary modifications are generally unnecessary. However, to support your treatment and protect your organs, you must adhere to the following safety guidelines:
Strict Avoidance Guidelines (What to Avoid):
Fortified Foods: Do not eat commercial breakfast cereals that have extra iron added to them. Read ingredient labels carefully.
Supplements: Do not take over-the-counter multivitamin supplements that contain iron. Additionally, avoid high-dose Vitamin C supplements, as Vitamin C significantly increases the amount of iron your intestines absorb from food.
Raw Shellfish: Strictly avoid eating raw oysters, clams, or mussels. High systemic iron levels create an ideal environment for the rapid growth of specific marine bacteria (such as Vibrio vulnificus) found in raw shellfish, which can trigger severe, life-threatening blood infections.
Alcohol Consumption: Strictly limit or moderate your alcohol intake. Alcohol increases the rate at which your body absorbs dietary iron and places heavy metabolic stress on a liver that may already be strained by iron deposition.
Advanced Tissue Toxicity and Organ Damage
If hereditary haemochromatosis is not diagnosed and aggressively treated in its early stages, the continuous, long-term accumulation of iron leads to severe cellular toxicity. The body has no natural way to excrete this surplus, causing it to damage the structure and function of vital organs.
Delayed treatment can lead to several major chronic health complications:
1. Advanced Hepatotoxicity (Liver Damage)
The liver serves as the primary storage site for iron, making it highly vulnerable to iron overload. Most individuals with untreated haemochromatosis experience some degree of hepatic injury. Chronic iron deposition triggers extensive cellular scarring, a severe condition known as cirrhosis.
Symptoms of Cirrhosis Include:
Chronic fatigue and profound physical weakness.
Unexplained weight loss and a persistent loss of appetite.
Frequent nausea or general stomach upset.
Severe, unremitting pruritus (itchy skin).
Tenderness, dull aches, or localized pain in the upper right quadrant of the abdomen.
Jaundice (a distinct yellowing of the skin and the whites of the eyes).
Clinical Management: Targeted surgical interventions and medications can effectively manage the symptoms and slow the progression of cirrhosis. However, once advanced liver failure occurs, a comprehensive liver transplant is the only permanent cure. Cirrhosis also drastically elevates your long-term statistical risk of developing primary liver cancer (hepatocellular carcinoma).
2. Secondary Diabetes Mellitus
Chronic iron buildup within the abdomen can directly infiltrate and damage the islet cells of the pancreas. Because the pancreas is responsible for synthesizing insulin—the hormone that regulates blood sugar—this tissue destruction can impair insulin production, resulting in secondary diabetes.
Symptoms of Pancreatic Damage Include:
Polyuria (an increased frequency of urination, particularly waking up multiple times at night).
Polydipsia (an unremitting, extreme sense of thirst).
Persistent, debilitating fatigue due to inefficient glucose utilization.
Clinical Management: Managing secondary diabetes requires dedicated lifestyle changes, including an optimized, low-glycemic diet and regular physical activity. Many patients will also require oral glucose-lowering medications or daily subcutaneous insulin injections to keep their blood sugar levels within a safe, targeted range.
3. Severe Arthropathy (Iron-Induced Arthritis)
Advanced, untreated haemochromatosis frequently causes iron crystals to deposit directly into the joint capsules, leading to a painful, progressive form of arthritis.
Musculoskeletal Symptoms Include:
Chronic, severe joint pain, characteristically presenting first in the knuckles of the first two fingers ("the haemochromatosis sign").
Persistent joint stiffness and a restricted range of motion.
Visible joint inflammation, warmth, and localized swelling.
Clinical Management: Early joint discomfort is typically managed using over-the-counter analgesics, prescription non-steroidal anti-inflammatory drugs (NSAIDs), or localized corticosteroid injections to suppress inflammation. However, if the iron deposition causes severe, irreversible structural destruction of the bone and cartilage, surgical total joint replacement (such as a hip or knee replacement) may be required.
4. Cardiomyopathy and Heart Failure
When excessive iron infiltrates the myocardium (heart muscle), it compromises the heart's structural elasticity and electrical pathways. This condition can lead to arrhythmias and progressive congestive heart failure, where the heart can no longer pump blood efficiently to meet the body's metabolic needs.
Cardiovascular Symptoms Include:
Dyspnea (shortness of breath), which frequently worsens when lying flat or during minor physical exertion.
Extreme, chronic fatigue and generalized physical weakness.
Peripheral oedema (visible, fluid-driven swelling in the lower legs, ankles, and feet).
Clinical Management: Iron-induced heart failure is a serious condition but can be managed effectively using a combinations of specialized cardiovascular medications (such as ACE inhibitors, beta-blockers, and diuretics) alongside aggressive therapeutic venesection to clear the heart tissue of toxic iron stores.
Disclaimer
The information provided here is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional or your GP for specific medical concerns, diagnoses, or health advice. Never disregard professional medical advice or delay seeking it because of information you have read here.
